Shares of Humana Inc. (NYSE:HUM – Get Free Report) reached a new 52-week high on Monday after Royal Bank Of Canada upgraded the stock from a sector perform rating to an outperform rating. Royal Bank Of Canada now has a $563.00 price target on the stock, up from their previous price target of $415.00. Humana traded as high as $458.00 and last traded at $457.73, with a volume of 7,160 shares trading hands. The stock had previously closed at $450.00.
Other research analysts have also recently issued reports about the stock. Mizuho raised their price objective on shares of Humana from $468.00 to $495.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 13th. Robert W. Baird raised Humana from a “neutral” rating to an “outperform” rating and increased their price objective for the company from $390.00 to $596.00 in a research note on Friday, October 9th. Wells Fargo & Company raised their price target on shares of Humana from $502.00 to $602.00 and gave the stock an “overweight” rating in a research note on Thursday. HSBC downgraded shares of Humana to a “hold” rating in a report on Thursday, July 30th. Finally, Piper Sandler increased their price target on Humana from $463.00 to $526.00 and gave the stock an “overweight” rating in a research note on Monday, November 9th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Humana currently has an average rating of “Moderate Buy” and an average target price of $482.96.
Check Out Our Latest Analysis on HUM
Insider Activity
In other Humana news, insider Joseph Ventura sold 5,495 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $433.85, for a total transaction of $2,384,005.75. Following the completion of the sale, the insider directly owned 21,910 shares in the company, valued at $9,505,653.50. The trade was a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.20% of the company’s stock.
Institutional Investors Weigh In On Humana
Hedge funds and other institutional investors have recently bought and sold shares of the business. Johnson Financial Group Inc. acquired a new stake in shares of Humana during the 2nd quarter valued at approximately $26,000. Trust Co. of Vermont acquired a new stake in shares of Humana during the second quarter worth $28,000. Bogart Wealth LLC lifted its position in shares of Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after buying an additional 48 shares during the last quarter. MidFirst Bank acquired a new position in shares of Humana in the 2nd quarter valued at about $35,000. Finally, Highland Investment Advisors LLC acquired a new position in shares of Humana in the 2nd quarter valued at about $43,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Humana Trading Up 0.9%
The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.61. The business’s 50-day moving average is $408.53 and its two-hundred day moving average is $316.91. The firm has a market cap of $54.54 billion, a P/E ratio of 44.06, a P/E/G ratio of 2.14 and a beta of 0.65.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Friday, November 6th. The insurance provider reported ($0.70) EPS for the quarter, beating analysts’ consensus estimates of ($1.00) by $0.30. Humana had a return on equity of 8.50% and a net margin of 0.81%. The company had revenue of $41.16 billion for the quarter, compared to analyst estimates of $40.87 billion. During the same period last year, the company earned $3.24 earnings per share. The company’s quarterly revenue was up 26.1% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.500- EPS. As a group, analysts expect that Humana Inc. will post 9.66 earnings per share for the current fiscal year.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 24th will be issued a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Thursday, December 24th. Humana’s payout ratio is presently 34.44%.
About Humana
Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.
Featured Articles
- Five stocks we like better than Humana
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
